Danske Bank’s Mersana Therapeutics MRSN Stock Holding History

Danske Bank’s Portfolio MRSN Stock Details MRSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1	Closed	-$29	–	1420
2025 Q4	$29	Hold	1	–	–	﹤0.01%	1457
2025 Q3	$8	Buy	+1	New	+$8	﹤0.01%	1424

Other funds holding MRSN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Danske Bank's MRSN Position: Q1 2026 in Review

Danske Bank sold out of Mersana Therapeutics (MRSN) in Q1 2026, closing a stake of 1 share — an estimated $29 sold.

Danske Bank first reported a position in MRSN in Q3 2025 and held it in 2 quarters. The position peaked at $29 in Q4 2025. 1 fund tracked by Wall St. Rank holds MRSN as of Q1 2026.

Danske Bank reported no remaining Mersana Therapeutics position as of Q1 2026 after selling out during the quarter.
Danske Bank sold 1 Mersana Therapeutics share in Q1 2026, an estimated $29.
Danske Bank first reported a position in Mersana Therapeutics in Q3 2025 and held it in 2 quarters.
Danske Bank's Mersana Therapeutics position peaked at $29 in Q4 2025.
1 fund tracked by Wall St. Rank held Mersana Therapeutics as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.